Oxbryta

List of products in the National Drug Code with proprietary name oxbryta. This medication is used to treat sickle cell disease. People with sickle cell disease have a certain abnormal protein (hemoglobin S) in their red blood cells that makes the cells stiff and irregularly shaped (sickle- or crescent moon-shaped). Voxelotor works by decreasing hemoglobin S. This effect may decrease symptoms such as tiredness, shortness of breath, and attacks of pain (sickle cell crisis).

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Labeler Name Product Type
72786-101Oxbryta VoxelotorTablet, Film CoatedOralGlobal Blood Therapeutics, Inc, A Subsidiary Of Pfizer Inc.Human Prescription Drug
72786-102Oxbryta VoxelotorTablet, Film CoatedOralGlobal Blood Therapeutics, Inc, A Subsidiary Of Pfizer Inc.Human Prescription Drug
72786-111Oxbryta VoxelotorTablet, For SuspensionOralGlobal Blood Therapeutics, Inc, A Subsidiary Of Pfizer Inc.Human Prescription Drug